Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?-Reference-Cited by-同舟云学术

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?

Published:2023-11-16 Issue: Volume: Page:
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Trevisan Lucia,Godino Lea,Battistuzzi Linda,Innella Giovanni,Luppi Elena,Buzzatti Giulia,Gismondi Viviana,Blondeaux Eva,Bonelli Luigina Ada,Turchetti Daniela,Varesco Liliana

Funder

Italian Ministry of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

https://link.springer.com/content/pdf/10.1007/s10689-023-00349-w.pdf

Reference33 articles.

1. Yoshida R (2021) Hereditary breast and Ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 28:1167–1180. https://doi.org/10.1007/s12282-020-01148-2

2. Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral Breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402. https://doi.org/10.1001/jama.2017.7112

3. Giri VN, Knudsen KE, Kelly WK et al (2020) Implementation of germline testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol 38:2798–2811. https://doi.org/10.1200/JCO.20.00046

4. Page EC, Bancroft EK, Brook MN et al (2019) Interim results from the IMPACT Study: evidence for prostate-specific Antigen Screening in BRCA2 mutation carriers. Eur Urol 76:831–842. https://doi.org/10.1016/j.eururo.2019.08.019

5. NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 1.2024)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2;Cancers;2023-12-06